HALLADAY BENJAMIN (Chief Financial Officer) sold 0.9% of their position (6.42K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001628280-26-019409
Officer· Chief Financial Officer
Since Nov 2022
-6.42K
Net shares
Net seller
$17.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.42K
Price / share
$2.71
Trade value
$17.38K
% of position
0.9%
3/17/2026
720.03K→713.60K
Total
Net shares
−6.42K
Net value
-$17.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −6.42K | $2.71 | $17.38K | 0.9% | 720.03K | 713.60K |
| Total | −6.42K | -$17.38K | ||||||
Derivative Transactions0
No derivative transactions reported